What If the Experiences We Medicate Are Exactly What They Appear to Be?

In 2016, a successful Hollywood producer named Joey Nittolo lost a close friend. What followed was not grief in any textbook sense. It was something that looked, to the people around him, like a psychotic break — auditory experiences, a sense of profound connection to something beyond himself, synchronicities so specific they resisted rational explanation. Within days, he was placed on a 5150 psychiatric hold. The diagnosis: schizophrenia.

But here is the question that the psychiatric system was not equipped to ask: What if the experience was real?

Not “real” in the sense of requiring no treatment or support. But real in the sense that it was a genuine transformative experience — one that, with the right framework, could have led to profound healing rather than a lifetime of antipsychotic medication. This is not a fringe question anymore. It is a question that peer-reviewed neuroscience, epigenetics, and transpersonal psychology are now forcing the medical establishment to confront.

Joey's story became the nucleus of CRAZY, Soul Syndicate's podcast that exists at the collision of three forces: the mental health crisis, the suppression of spiritual experience, and the question of whether those two things are the same problem.

This article is a deep investigation into the science behind that question. We follow the evidence from the molecular biology of inherited trauma, through the neuroscience of spiritual experience, to the uncomfortable possibility that Western medicine — for all its achievements — may be systematically misdiagnosing one of the most important phenomena in human consciousness.

Every claim is cited. Every number is sourced. And the conclusion may challenge everything you think you know about the boundary between breakdown and breakthrough.

For decades, the central dogma of biology held that your DNA was your destiny, and that lived experience could not alter what you passed to your children. That dogma is now in ruins.

Epigenetics — the study of how genes are switched on or off without changing the DNA sequence itself — has revealed that trauma does not just live in memory. It lives in the body. More precisely, it lives in the chemical markers that sit on top of your DNA and determine which genes are expressed and which are silenced. And those markers, the research now shows, can be inherited.

The landmark work belongs to Rachel Yehuda, a neuroscientist at the Icahn School of Medicine at Mount Sinai. In a 2016 study published in Biological Psychiatry, Yehuda and her team examined the FKBP5 gene — a critical regulator of the stress hormone cortisol — in Holocaust survivors and their adult children. What they found was molecular evidence of intergenerational trauma: both generations showed altered methylation patterns at the same gene, despite the children never experiencing the Holocaust.

This was not the first clue. A decade earlier, Yehuda had shown that babies born to mothers who developed PTSD from the September 11 World Trade Center attacks had significantly lower cortisol levels — the same neuroendocrine signature found in their traumatized mothers. The effect was strongest in babies whose mothers were in their third trimester during the attacks.

But perhaps the most visceral evidence came from an animal study. Brian Dias and Kerry Ressler at Emory University conditioned mice to fear a specific scent — acetophenone, which smells like cherries. The mice would freeze in terror when exposed to it. Then the researchers examined the offspring. And the grand-offspring. Neither generation had ever been conditioned. Yet both showed heightened fear responses to that exact scent and to no other. The fear had been transmitted through epigenetic changes in sperm DNA methylation affecting olfactory receptor genes. Their 2014 study in Nature Neuroscience provided some of the most striking evidence yet: acquired fears can be biologically inherited.

Mark Wolynn, author of It Didn't Start with You, has spent decades in clinical practice connecting patients' anxiety, depression, chronic pain, and phobias to specific traumas in their parents, grandparents, and even great-grandparents. His Core Language Approach identifies inherited trauma through the specific words, phrases, and physical symptoms patients unconsciously carry from previous generations — language patterns they could not have learned through direct experience.

And here is where the science connects to something Joey Nittolo described in his own words: the idea that “the things and the exchanges they lived are part of who we become.” He was not speaking metaphorically. He was, without knowing the technical vocabulary, describing the mechanism of epigenetic inheritance.

The implications are staggering. If trauma can be inherited, then healing may need to address not just your own experiences, but the unprocessed pain of generations before you. And here, our own scientific advisor offers a critical insight.

Here is something you can verify in under two minutes. Open the DSM-5 — the psychiatric profession's diagnostic bible — and look at the symptom criteria for a psychotic episode. Then search “spiritual awakening symptoms” in any reputable source. The lists are, as Joey Nittolo put it, mirrors of each other.

Auditory experiences. A sense of cosmic significance. The dissolution of the ordinary sense of self. Altered perception of time. Intense emotional states. Feeling connected to something vastly larger than oneself. In the psychiatric framework, these are symptoms to be eliminated. In the contemplative traditions of every major civilization in human history, they are the hallmarks of transformation.

The first clinician to systematically address this overlap was psychiatrist Stanislav Grof. A Czech-born researcher who began his career studying LSD-assisted psychotherapy in the 1960s, Grof spent decades documenting what he called “spiritual emergency” — a transformative crisis that, if properly supported, leads to profound healing and personal growth, but if misdiagnosed and suppressed with antipsychotic medication, can prevent the natural healing process from completing.

Grof identified ten distinct types of spiritual emergency, including kundalini awakening, shamanic crisis, past-life experiences, psychic opening, and what he called “the dark night of the soul.” His 1989 book Spiritual Emergency argued that these crises are not pathological but developmental — a painful but necessary stage in psychological and spiritual maturation.

The psychiatric establishment initially dismissed Grof's work. But the evidence kept accumulating. In 1994, psychologist David Lukoff achieved something remarkable: he led the successful effort to include “Religious or Spiritual Problem” (V62.89) as a diagnostic category in the DSM-IV. For the first time, the psychiatric establishment formally acknowledged that spiritual experiences could be clinically significant without being pathological.

That category still exists in the DSM-5. Yet it remains one of the most underutilized diagnostic codes in clinical practice. A generation of psychiatrists trained in the pharmaceutical paradigm default to pathological explanations — and pharmaceutical solutions — for experiences that may be neither pathological nor best served by medication.

Psychiatrist Bruce Greyson, after decades of studying near-death and spiritual experiences at the University of Virginia, established the clinical markers that distinguish the two states: spiritual experiences are typically brief, self-limiting, and associated with enhanced psychological functioning afterward. Psychotic episodes show the opposite pattern — persistent disorganization, declining function, and social deterioration. The distinction is clinically actionable. The question is whether the system is trained to apply it.

And then there is Lisa Miller's research at Columbia University. In a 2014 study published in JAMA Psychiatry, Miller found that adults who reported high importance of spirituality had measurably thicker cortical brain tissue in the parietal and occipital regions — the exact regions that thin in people at high familial risk for depression. Spirituality was generating a neurological protective shield against depression, even in people genetically predisposed to the disorder. If the system is suppressing these experiences, Miller's data suggests, it may be suppressing the very mechanism that protects against the conditions it claims to treat.

Joey Nittolo used the word “frequency” to describe spiritual experience. It sounds like New Age language. It is also, as it turns out, literally accurate.

Andrew Newberg, a neuroscientist at Thomas Jefferson University, pioneered the field of neurotheology — the scientific study of what happens in the brain during spiritual experiences. Using SPECT imaging on Tibetan Buddhist meditators and Franciscan nuns during their deepest states of prayer and meditation, Newberg documented dramatic decreases in parietal lobe activity. The parietal lobe is the brain's orientation center — it maintains the boundary between self and the world. When its activity drops, the neurological basis for the feeling of “oneness” and dissolution of self-other boundaries emerges. This happened consistently, regardless of the practitioner's religious tradition. The mystical experience has a neural signature, and it is the same across belief systems.

Cahn's broader body of work reinforces this. His 2017 study across three different meditation traditions — Vipassana, Himalayan Yoga, and Isha Shoonya — found that all three produced significant increases in gamma brainwave amplitude compared to non-meditating controls. Gamma waves are associated with heightened awareness, cognitive integration, and states of insight. Three different practices, rooted in three different cultures and three different theological frameworks, producing the same neurological result. This is not mysticism. This is measurement.

Long-term meditators don't just show different brain activity during practice. Newberg's subsequent research found they show permanently increased cerebral blood flow in the prefrontal cortex, thalamus, and midbrain — regions governing attention, emotional regulation, and executive function — even when they are not meditating. The practice, sustained over time, physically rewires the brain.

Now consider what this means for the people Joey described — individuals in psychiatric institutions reporting experiences of cosmic connection, hearing voices, experiencing visions. The neuroscience confirms that states of expanded consciousness are real brain events with measurable, consistent signatures. The question the system is not asking is whether some of those patients are experiencing pathology and others are experiencing a neurological event that, in a different cultural context, would be recognized as growth.

The global psychiatric drug market exceeds $500 billion annually. The incentive structure is straightforward: pathologize the experience, prescribe the medication, renew the prescription. This is not a conspiracy theory. It is a business model. And it has produced remarkable outcomes for many people. SSRIs save lives. Antipsychotics prevent suffering. Psychiatric medication is not the enemy.

But a business model that profits from medication does not naturally invest in asking whether some of its patients would be better served by a different framework entirely. And that is where the blind spot lives.

The evidence presented in this article suggests that Western psychiatry may be operating with an incomplete map. Epigenetics shows us that the traumas driving mental health crises may span generations — and that body-based, experiential therapies can reverse these inherited patterns at the molecular level. Neuroscience shows us that spiritual experiences are measurable brain events with consistent signatures. Transpersonal psychology shows us that experiences currently labeled as psychotic can, with proper support, resolve into enhanced well-being and personal growth.

The question is not whether medication has value. It does. The question is whether a system built primarily around medication has the framework to recognize when something else is called for.

Encouragingly, that framework is beginning to emerge. Dr. Rael Cahn's work at USC represents one frontier: his ketamine-assisted mindfulness training program at LAC+USC Medical Center combines pharmaceutical intervention with contemplative practice, treating both the neurochemistry and the experiential dimension. His MAPS-affiliated research on MDMA-assisted therapy demonstrates that the most effective healing may happen when medicine and spiritual experience are integrated rather than opposed.

There is also the story of Reverend Michael Bernard Beckwith, the founder of Agape International Spiritual Center. Beckwith attended USC, had a profound spiritual awakening, and became one of the most recognized spiritual leaders in the world. His experience parallels Joey Nittolo's in striking ways — a sudden, overwhelming opening that could have been pathologized but instead became the foundation of a life dedicated to consciousness and service. Beckwith, notably, is one of the subjects in Soul Syndicate's upcoming investigation — a living case study in what happens when a transformative experience is supported rather than suppressed.

Bessel van der Kolk, whose seminal work The Body Keeps the Score synthesized three decades of trauma research, demonstrated that body-based therapies — yoga, EMDR, neurofeedback — can succeed where talk therapy and medication alone fail, because they address trauma where it actually lives: in the nervous system. His work reframes healing as something that happens not through chemical intervention alone, but through experiences that engage the whole organism — body, mind, and what many patients and practitioners describe as spirit.

If you have read this far, you may be asking the most personal version of the question this article investigates: does this apply to me? If you have experienced anxiety that seems disproportionate to your life circumstances. If depression runs in your family. If you've had experiences — in meditation, in crisis, in moments of extreme emotion — that felt like something more than your training prepared you to explain.

The research suggests a few practical frameworks worth considering: